Idress receives NIH BIRCWH award to study GIP/GLP‑1 therapy on osteosarcopenia

Share
Idress receives NIH BIRCWH award to study GIP/GLP‑1 therapy on osteosarcopenia

We are excited to congratulate GCDTR's Thayer I., MD, Assistant Professor of Medicine in Emory University’s Division of Endocrinology, Metabolism & Lipids, on his NIH-funded BIRCWH Program award! Dr. Idress will lead important research on the impact of GIP/GLP-1 RA therapy on osteosarcopenia in older women with diabetes.

This award provides career development support, research funding, and mentorship, and reflects Dr. Idress’s commitment to advancing diabetes and aging research. Congratulations, Dr. Idress!

Back to News
Share